1. DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs
   Jianqiang Zhang et al, 2019, Frontiers in Immunology CrossRef
2. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
   Claude Roberge et al, 2007, American Journal of Physiology-Endocrinology and Metabolism CrossRef
3. What's New in Endocrinology: The Chromaffin Cell
   Lee E. Eiden et al, 2018, Frontiers in Endocrinology CrossRef
4. Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma
   Philippe J. Eugster et al, 2022, Clinica Chimica Acta CrossRef